Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.
This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosciences ...
He was surprised to discover, for example, that a photo of the GSK headquarters building attracted more positive comments than a story about a community partnership. A recent example of content ...
DONALD Trump has announced tariffs on all goods imported to the US, which could see the price of some everyday items rise in ...
1d
Cryptopolitan on MSNTrump’s tariffs are affecting unlikely industries, targeting America’s cosmetic and weight loss marketsPresident Donald Trump is expected to announce sweeping tariffs on “all countries" affecting many industries, the likes of ...
Me’s genetic data may be for sale after bankruptcy. AI firms may want in—but privacy fears could make it a toxic asset.
10don MSN
The pharmaceutical company GlaxosmithKline has also fallen on the list ... The tech company has its North American ...
Billionaire Dalio, head of the world's largest hedge fund, is considered a global authority on investing in China. The bank ...
Among its measures, Roche said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on inclusion ...
Roche (ROG.S), opens new tab said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on inclusion and belonging, and responsibilities will be re-scoped accordingly".
23andMe cofounder and CEO Anne Wojcicki stepped down and the company filed for Chapter 11 bankruptcy protection, it said ...
Roche said its Chief Diversity Offices in the U.S. and at its Basel headquarters "will focus on inclusion and belonging, and responsibilities will be re-scoped accordingly". Diversity was not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results